Skip to content
10-Q

Quarterly Report

ELECTROMEDICAL TECHNOLOGIES, INC. EMED

0001410578-24-001410

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 13, 2024 623.85M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.94B sh
Shares Diluted Q2 2024 · Jun 30, 2024 515.74M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 335.5M sh
Shares Diluted Q2 2024 · Jun 30, 2023 288.05M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$49.43K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$1.09M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $116.93K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $87.7K
Stockholders Equity Q2 2024 · Jun 30, 2024 −$3.4M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$3.69M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$2.87M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$2.28M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$1.03M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$2.22M
Current Liabilities Q2 2024 · Jun 30, 2024 $3.83M
Current Liabilities Q2 2024 · Dec 31, 2023 $3.36M
Total Liabilities Q2 2024 · Jun 30, 2024 $4.06M
Total Liabilities Q2 2024 · Dec 31, 2023 $3.62M
Current Assets Q2 2024 · Jun 30, 2024 $389.22K
Current Assets Q2 2024 · Dec 31, 2023 $449.19K
Total Assets Q2 2024 · Jun 30, 2024 $664.96K
Total Assets Q2 2024 · Dec 31, 2023 $748.38K
Eps Diluted Q2 2024 · Jun 30, 2024 $0.00
Eps Diluted Q2 2024 · Jun 30, 2024 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.01
Eps Basic Q2 2024 · Jun 30, 2024 $0.00
Eps Basic Q2 2024 · Jun 30, 2024 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 −$0.01
Sga Expense Q2 2024 · Jun 30, 2024 $425.1K
Sga Expense Q2 2024 · Jun 30, 2024 $797.36K
Sga Expense Q2 2024 · Jun 30, 2023 $573.84K
Sga Expense Q2 2024 · Jun 30, 2023 $2.13M
Net Income Q2 2024 · Jun 30, 2024 $231.24K
Net Income Q2 2024 · Jun 30, 2024 −$605.04K
Net Income Q2 2024 · Mar 31, 2024 −$836.27K
Net Income Q2 2024 · Jun 30, 2023 −$1.46M
Net Income Q2 2024 · Jun 30, 2023 −$1.92M
Net Income Q2 2024 · Mar 31, 2023 −$456.06K
Operating Income Q2 2024 · Jun 30, 2024 −$251.85K
Operating Income Q2 2024 · Jun 30, 2024 −$406.72K
Operating Income Q2 2024 · Jun 30, 2023 −$341.4K
Operating Income Q2 2024 · Jun 30, 2023 −$1.6M
Gross Profit Q2 2024 · Jun 30, 2024 $173.26K
Gross Profit Q2 2024 · Jun 30, 2024 $390.64K
Gross Profit Q2 2024 · Jun 30, 2023 $232.44K
Gross Profit Q2 2024 · Jun 30, 2023 $523.39K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $64.39K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $137.25K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $62.52K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $150.22K
Revenue Q2 2024 · Jun 30, 2024 $237.65K
Revenue Q2 2024 · Jun 30, 2024 $527.89K
Revenue Q2 2024 · Jun 30, 2023 $294.95K
Revenue Q2 2024 · Jun 30, 2023 $673.6K
Capex Q2 2024 · Jun 30, 2023 $149.71K